Historically, the FDA has notified drug manufacturers outside of the United States of drug inspections weeks or even months ahead of time. The Senate Committee on Finance believes this gives foreign drug facilities ample time to correct or conceal noncompliance. However, U.S.-based drug manufacturers aren’t afforded the luxury of pre-announced inspections. According to a recent SIDLEY article, a newly introduced bill wants to eliminate the delay between notice and inspection for manufacturers abroad.
New Bill Wants to Do Away with Advance Notice for Foreign Drug Inspections
The proposed bill aims to level the playing field between domestic and foreign surveillance inspections.
Feb 7, 2022
Recommended
Recommended
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
